iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE
- Instituto Gulbenkian de Ciência, Portugal
- Trinity College, Dublin, Ireland
- Academy of Sciences of the Czech Republic, Czech Republic
- Albert Ludwigs Universitaet, Germany
- University of Vienna, Austria
- University of Edinburgh, United Kingdom
Abstract
The apical inflammatory cytokine TNF regulates numerous important biological processes including inflammation and cell death, and drives inflammatory diseases. TNF secretion requires TACE (also called ADAM17), which cleaves TNF from its transmembrane tether. The trafficking of TACE to the cell surface, and stimulation of its proteolytic activity, depends on membrane proteins, called iRhoms. To delineate how the TNF/TACE/iRhom axis is regulated, we performed an immunoprecipitation/mass spectrometry screen to identify iRhom-binding proteins. This identifies a novel protein, that we name iTAP (iRhom Tail-Associated Protein) that binds to iRhoms, enhancing the cell surface stability of iRhoms and TACE, preventing their degradation in lysosomes. Depleting iTAP in primary human macrophages profoundly impaired in TNF production and tissues from iTAP KO mice exhibit a pronounced depletion in active TACE levels. Our work identifies iTAP as a physiological regulator of TNF signalling and a novel target for the control of inflammation.
Data availability
We have provided the source data for all experiments that involved quantitative analyses.
Article and author information
Author details
Funding
Worldwide Cancer Research (14-1289)
- Colin Adrain
Fundação para a Ciência e a Tecnologia (PTDC/BEX-BCM/3015/2014)
- Colin Adrain
Fundação para a Ciência e a Tecnologia (SFRH/ BPD/117216/2016)
- Miguel Cavadas
Fundação para a Ciência e a Tecnologia (91/BD/14)
- Ioanna Oikonomidi
Fundação para a Ciência e a Tecnologia (SFRH/BCC/52507/2014)
- Colin Adrain
Fundação Calouste Gulbenkian
- Colin Adrain
Seventh Framework Programme (Marie Curie Career Integration Grant (project no. 618769)
- Colin Adrain
The European Crohns and Colitis Organization
- Colin Adrain
Science Foundation Ireland (14/IA/2622)
- Seamus J Martin
European Molecular Biology Organization (Installation Grant no. 2329)
- Kvido Strisovsky
Ministry of Education, Youth and Sports of the Czech Republic (LO1302)
- Kvido Strisovsky
European Regional Development Fund (CZ.2.16/3.1.00/24016)
- Kvido Strisovsky
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: Experiments with mice were performed in accordance with protocols approved by the Ethics Committee of the Instituto Gulbenkian de Ciencia and the Portuguese National Entity (DGAV- Direcao Geral de Alimentacao e Veterinaria) and in accordance with the Portuguese (Decreto-Lei no. 113/2013) and European (directive 2010/63/EU) legislation related to housing, husbandry, and animal welfare.
Human subjects: Human bloods were obtained from healthy volunteers with informed consent, after review and approval by Trinity College Dublin's research ethics committee.
Copyright
© 2018, Oikonomidi et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,778
- views
-
- 441
- downloads
-
- 56
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE
eLife 7:e35032.
https://doi.org/10.7554/eLife.35032
Further reading
-
- Biochemistry and Chemical Biology
- Genetics and Genomics
Yerba mate (YM, Ilex paraguariensis) is an economically important crop marketed for the elaboration of mate, the third-most widely consumed caffeine-containing infusion worldwide. Here, we report the first genome assembly of this species, which has a total length of 1.06 Gb and contains 53,390 protein-coding genes. Comparative analyses revealed that the large YM genome size is partly due to a whole-genome duplication (Ip-α) during the early evolutionary history of Ilex, in addition to the hexaploidization event (γ) shared by core eudicots. Characterization of the genome allowed us to clone the genes encoding methyltransferase enzymes that catalyse multiple reactions required for caffeine production. To our surprise, this species has converged upon a different biochemical pathway compared to that of coffee and tea. In order to gain insight into the structural basis for the convergent enzyme activities, we obtained a crystal structure for the terminal enzyme in the pathway that forms caffeine. The structure reveals that convergent solutions have evolved for substrate positioning because different amino acid residues facilitate a different substrate orientation such that efficient methylation occurs in the independently evolved enzymes in YM and coffee. While our results show phylogenomic constraint limits the genes coopted for convergence of caffeine biosynthesis, the X-ray diffraction data suggest structural constraints are minimal for the convergent evolution of individual reactions.
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
The SARS-CoV-2 main protease (Mpro or Nsp5) is critical for production of viral proteins during infection and, like many viral proteases, also targets host proteins to subvert their cellular functions. Here, we show that the human tRNA methyltransferase TRMT1 is recognized and cleaved by SARS-CoV-2 Mpro. TRMT1 installs the N2,N2-dimethylguanosine (m2,2G) modification on mammalian tRNAs, which promotes cellular protein synthesis and redox homeostasis. We find that Mpro can cleave endogenous TRMT1 in human cell lysate, resulting in removal of the TRMT1 zinc finger domain. Evolutionary analysis shows the TRMT1 cleavage site is highly conserved in mammals, except in Muroidea, where TRMT1 is likely resistant to cleavage. TRMT1 proteolysis results in reduced tRNA binding and elimination of tRNA methyltransferase activity. We also determined the structure of an Mpro-TRMT1 peptide complex that shows how TRMT1 engages the Mpro active site in an uncommon substrate binding conformation. Finally, enzymology and molecular dynamics simulations indicate that kinetic discrimination occurs during a later step of Mpro-mediated proteolysis following substrate binding. Together, these data provide new insights into substrate recognition by SARS-CoV-2 Mpro that could help guide future antiviral therapeutic development and show how proteolysis of TRMT1 during SARS-CoV-2 infection impairs both TRMT1 tRNA binding and tRNA modification activity to disrupt host translation and potentially impact COVID-19 pathogenesis or phenotypes.
